0001193125-11-138919.txt : 20110513
0001193125-11-138919.hdr.sgml : 20110513
20110513113206
ACCESSION NUMBER: 0001193125-11-138919
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110331
FILED AS OF DATE: 20110513
DATE AS OF CHANGE: 20110513
EFFECTIVENESS DATE: 20110513
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Abingworth LLP
CENTRAL INDEX KEY: 0001397144
IRS NUMBER: 980518585
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14285
FILM NUMBER: 11838898
BUSINESS ADDRESS:
STREET 1: 38 JERMYN STREET
CITY: LONDON
STATE: X0
ZIP: SW1Y 6DN
BUSINESS PHONE: 44 (0)20 7534 1500
MAIL ADDRESS:
STREET 1: 38 JERMYN STREET
CITY: LONDON
STATE: X0
ZIP: SW1Y 6DN
13F-HR
1
d13fhr.txt
FORM 13F
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2011
Check here if Amendment [_]; Amendment Number: ________________________________
This Amendment (Check only one.): [_] is a restatement.
[_] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Abingworth LLP
Address: Princes House, 38 Jermyn Street, London, England SW1Y 6DN
Form 13F File Number: 28-14285
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: James Abell
Title: Member
Phone: +44 (0)20 7534 1500
Signature, Place, and Date of Signing:
/s/ James Abell London, United Kingdom May 9, 2011
----------------------- ------------------------ -----------------------
(Name) (City, State) (Date)
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[_] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
================================================================================
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 1
Form 13F Information Table Entry Total: 27 items
Form 13F Information Table Value Total: $195,981 (thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
No. Form 13F File Number Name
1 Not applicable Abingworth Management Limited
FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
-------- --------- --------- -------- ------------------- ---------- -------- ----------------------
VOTING AUTHORITY
TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER ----------------------
NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
-------------- --------- --------- -------- ---------- --- ---- ---------- -------- ---------- ------ ----
AFFYMETRIX INC COM 00826T108 1,281 246,253 SH DEFINED 1 246,253
ALEXZA PHARMACEUTICALS INC COM 15384100 4,849 2,869,207 SH DEFINED 1 2,869,207
ALLOS THERAPEUTICS INC COM 19777101 837 265,000 SH DEFINED 1 265,000
ALNYLAM PHARMACEUTICALS INC COM 02043Q107 17,342 1,814,053 SH DEFINED 1 1,814,053
AMARIN CORP PLC SPONS ADR 23111206 88,148 12,075,000 SH DEFINED 1 12,075,000
AVANIR PHARMACEUTICALS INC CL A 05348P401 458 112,500 SH DEFINED 1 112,500
CELLDEX THERAPEUTICS INC COM 15117B103 1,380 343,396 SH DEFINED 1 343,396
CALIPER LIFE SCIENCES INC COM 130872104 4,242 627,501 SH DEFINED 1 627,501
CARDIOME PHARMA CORP COM 14159U202 2,053 480,856 SH DEFINED 1 480,856
CELGENE CORP COM 151020104 5,235 90,994 SH DEFINED 1 90,994
CORNERSTONE THERAPEUTICS INC COM 21924P103 561 84,742 SH DEFINED 1 84,742
ENTREMED INC COM 29382F202 362 70,760 SH DEFINED 1 70,760
EXELIXIS INC COM 30161Q104 4,685 415,000 SH DEFINED 1 415,000
INCYTE CORP COM 45337C102 13,154 830,417 SH DEFINED 1 830,417
ISIS PHARMACEUTICALS INC NOTE 464337AE4 1,229 1,280 PRN DEFINED 1 1,280
ISIS PHARMACEUTICALS INC COM 464330109 2,416 267,578 SH DEFINED 1 267,578
MICROMET INC COM 59509C105 9,396 1,677,860 SH DEFINED 1 1,677,860
NEKTAR THERAPEUTICS COM 640268108 6,281 663,946 SH DEFINED 1 663,946
NOVAVAX INC COM 670002104 3,895 1,503,824 SH DEFINED 1 1,503,824
NPS PHARMACEUTICALS INC COM 62936P103 4,761 497,500 SH DEFINED 1 497,500
ONCOGENEX PHARMACEUTICALS INC COM 68230A106 6,826 447,590 SH DEFINED 1 447,590
PONIARD PHARMACEUTICALS INC COM 732449301 77 182,239 SH DEFINED 1 182,239
SUNESIS PHARMACEUTICALS INC COM 867328502 248 129,358 SH DEFINED 1 129,358
MEDICINES CO COM 584688105 1,742 107,000 SH DEFINED 1 107,000
TRIMERIS INC COM 896263100 794 320,000 SH DEFINED 1 320,000
ZALICUS INC COM 98887C105 2,100 864,044 SH DEFINED 1 864,044
ZOGENIX INC COM 98978L105 11,629 2,335,218 SH DEFINED 1 2,335,218